View : 514 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김대기*
dc.date.accessioned2018-05-02T08:15:42Z-
dc.date.available2018-05-02T08:15:42Z-
dc.date.issued2004*
dc.identifier.issn0960-894X*
dc.identifier.otherOAK-2160*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/242775-
dc.description.abstractA series of 2-pyridinyl-[1,2,3]triazoles have been synthesized and evaluated for their ALK5 inhibitory activity in the luciferase reporter assays. Compound 8d showed significant ALK5 inhibition (SBE-luciferase activity, 25%; p3TP-luciferase activity, 17%) at a concentration of 5μM that is comparable to that of SB-431542 (SBE-luciferase activity, 21%; p3TP-luciferase activity, 12%), but weak p38α MAP kinase inhibition (13%) at a concentration of 10μM that is much lower than that of SB-431542 (54%). © 2004 Elsevier Ltd. All rights reserved.*
dc.languageEnglish*
dc.titleSynthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor*
dc.typeArticle*
dc.relation.issue10*
dc.relation.volume14*
dc.relation.indexSCI*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.startpage2401*
dc.relation.lastpage2405*
dc.relation.journaltitleBioorganic and Medicinal Chemistry Letters*
dc.identifier.doi10.1016/j.bmcl.2004.03.024*
dc.identifier.wosidWOS:000221316000003*
dc.identifier.scopusid2-s2.0-1942534588*
dc.author.googleKim D.-K.*
dc.author.googleKim J.*
dc.author.googlePark H.-J.*
dc.contributor.scopusid김대기(35083694200)*
dc.date.modifydate20240118164500*
Appears in Collections:
약학대학 > 약학과 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE